Aspirin for dual prevention of venous and arterial thrombosis

New England Journal of Medicine

Volumn 367, Issue 21, 2012, Pages 2039-2041

  Warkentin, Theodore E ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; FONDAPARINUX; HEPARIN; RIVAROXABAN; WARFARIN;

ANTICOAGULATION; ARTERIAL CIRCULATION; ARTERY THROMBOSIS; EDITORIAL; HIP ARTHROPLASTY; HUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84869412681     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1211480     Document Type: Editorial

References (9)

1. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. [Erratum, BMJ 2002;324:141.]
2. Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977;297:1246-9.
3. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:Suppl:e278S-e325S.
4. Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012;366:1959-67.
5. Brighton TA, Eikelboom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012;367:1979-87.
6. Boutitie F, Pinede L, Schulman S, et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 2011;342:d3036.
7. Kearon C. A conceptual framework for two phases of anti-coagulant treatment of venous thromboembolism. J Thromb Haemost 2012;10:507-11.
8. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
9. Green D. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism. Hematology Am Soc Hematol Educ Program 2009;1:259-66.